101 related articles for article (PubMed ID: 7512181)
1. The bovine leukemia virus (BLV) envelope glycoprotein gp51 as a general model for the design of a subunit vaccine against retroviral infection: mapping of functional sites through immunological and structural data.
Callebaut I; Mornon JP; Burny A; Portetelle D
Leukemia; 1994 Apr; 8 Suppl 1():S218-21. PubMed ID: 7512181
[TBL] [Abstract][Full Text] [Related]
2. Development of a specific serological test and an efficient subunit vaccine to control bovine leukemia virus infection.
Portetelle D; Burny A; Desmettre P; Mammerickx M; Paoletti E; Zavada J
Dev Biol Stand; 1990; 72():81-90. PubMed ID: 1704325
[TBL] [Abstract][Full Text] [Related]
3. Identification of an immunodominant region on the isolated bovine leukaemia virus (BLV) major envelope protein gp51 by monoclonal antibodies presumably not exposed during natural BLV infection.
Platzer C; Siakkou H; Sober J; Kopp J; Scheve E; Rosenthal S
Acta Virol; 1990 May; 34(3):246-55. PubMed ID: 1980398
[TBL] [Abstract][Full Text] [Related]
4. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
[TBL] [Abstract][Full Text] [Related]
5. Peptide-based bovine leukemia virus (BLV) vaccine that induces BLV-Env specific Th-1 type immunity.
Ohishi K; Kabeya H; Amanuma H; Onuma M
Leukemia; 1997 Apr; 11 Suppl 3():223-6. PubMed ID: 9209348
[TBL] [Abstract][Full Text] [Related]
6. Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51.
Callebaut I; Vonèche V; Mager A; Fumière O; Krchnak V; Merza M; Zavada J; Mammerickx M; Burny A; Portetelle D
J Virol; 1993 Sep; 67(9):5321-7. PubMed ID: 7688821
[TBL] [Abstract][Full Text] [Related]
7. Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.
Ban J; Czene S; Altaner C; Callebaut I; Krchnak V; Merza M; Burny A; Kettmann R; Portetelle D
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2457-61. PubMed ID: 1383413
[TBL] [Abstract][Full Text] [Related]
8. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.
Portetelle D; Dandoy C; Burny A; Zavada J; Siakkou H; Gras-Masse H; Drobecq H; Tartar A
Virology; 1989 Mar; 169(1):34-41. PubMed ID: 2466371
[TBL] [Abstract][Full Text] [Related]
9. Antigenic variants of bovine leukemia virus (BLV) are defined by amino acid substitutions in the NH2 part of the envelope glycoprotein gp51.
Portetelle D; Couez D; Bruck C; Kettmann R; Mammerickx M; Van der Maaten M; Brasseur R; Burny A
Virology; 1989 Mar; 169(1):27-33. PubMed ID: 2466370
[TBL] [Abstract][Full Text] [Related]
10. Elicitation of bovine antibody to BLV-gp51 by BLV-vaccination.
Maruyama K; Fukushima T; Mochizuki S; Abe H; Onuma M; Hasegawa A; Misawa M
Leukemia; 1988 Dec; 2(12 Suppl):216S-222S. PubMed ID: 2848999
[TBL] [Abstract][Full Text] [Related]
11. Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.
Callebaut I; Burny A; Krchnák V; Gras-Masse H; Wathelet B; Portetelle D
Virology; 1991 Nov; 185(1):48-55. PubMed ID: 1718088
[TBL] [Abstract][Full Text] [Related]
12. Ovine MHC class II DRB1 alleles associated with resistance or susceptibility to development of bovine leukemia virus-induced ovine lymphoma.
Nagaoka Y; Kabeya H; Onuma M; Kasai N; Okada K; Aida Y
Cancer Res; 1999 Feb; 59(4):975-81. PubMed ID: 10029093
[TBL] [Abstract][Full Text] [Related]
13. An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep.
Kabeya H; Ohashi K; Ohishi K; Sugimoto C; Amanuma H; Onuma M
Vaccine; 1996 Aug; 14(12):1118-22. PubMed ID: 8911007
[TBL] [Abstract][Full Text] [Related]
14. [Exposure of the major immunodominant epitope of the gp51 envelope protein of bovine leukosis virus on the surface of the hepatitis B core antigen capsid].
Ul'rikh R; Borisova GP; Siakkou Kh; Plattser K; Ose VP; Berzin' IG; Dreĭlinia DE; Pushko PM; Tsibinogin VV; Pumpen PP
Mol Biol (Mosk); 1991; 25(2):368-74. PubMed ID: 1715509
[TBL] [Abstract][Full Text] [Related]
15. Immunological characterization of BLV proteins synthesized in Escherichia coli.
Siakkou H; Ulrich R; Uelze A; Möhring R; Rosenthal S
Acta Virol; 1990 May; 34(3):256-62. PubMed ID: 1703391
[TBL] [Abstract][Full Text] [Related]
16. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
[TBL] [Abstract][Full Text] [Related]
17. T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development.
Gatei MH; Good MF; Daniel RC; Lavin MF
J Virol; 1993 Apr; 67(4):1796-802. PubMed ID: 7680386
[TBL] [Abstract][Full Text] [Related]
18. Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1.
Orlik O; Ban J; Hlavaty J; Altaner C; Kettmann R; Portetelle D; Splitter GA
J Virol; 1997 Apr; 71(4):3263-7. PubMed ID: 9060692
[TBL] [Abstract][Full Text] [Related]
19. Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development.
Miyazawa M; Fujisawa R; Ishihara C; Takei YA; Shimizu T; Uenishi H; Yamagishi H; Kuribayashi K
J Immunol; 1995 Jul; 155(2):748-58. PubMed ID: 7541823
[TBL] [Abstract][Full Text] [Related]
20. [Use of a monoclonal antibody against envelope protein gp51 of bovine leukemia virus in a test for the diagnosis of enzootic bovine leukosis].
Siakkou H; Platzer C; Beier D; Olechnowitz AF; Rosenthal S
Arch Exp Veterinarmed; 1990; 44(2):223-31. PubMed ID: 2167049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
